SUNOSI® (Solriamfetol) Pregnancy Registry: An Observational Study on the Safety of Solriamfetol Exposure in Pregnant Women and Their Offspring
Latest Information Update: 17 May 2024
At a glance
- Drugs Solriamfetol (Primary)
- Indications Narcolepsy; Sleep apnoea syndrome
- Focus Adverse reactions
- Sponsors Axsome Therapeutics
Most Recent Events
- 17 May 2024 New trial record